/content/dam/www/people-profile-photos/r/armin-rashidi/provider-armin-rashidi-directory-1x.jpg
/content/dam/www/people-profile-photos/r/armin-rashidi/provider-armin-rashidi-directory-2x.jpg
Rashidi
Armin Rashidi, MD, PhD

Armin Rashidi, MD, PhD

Hematology-Oncology

  • Physician, Fred Hutch
  • Associate Professor, Clinical Research Division, Fred Hutch
  • Affiliate Investigator, Translational Science and Therapeutics Division, Fred Hutch
  • Associate Professor, Division of Hematology and Oncology, University of Washington School of Medicine
Request an Appointment

About

Dr. Armin Rashidi is an oncologist and researcher at Fred Hutch. His clinical care in blood and marrow transplantation and cellular therapy is combined with research on how the microbiome affects outcomes after treatment for blood cancers.

Background

Dr. Rashidi cares for patients undergoing blood and marrow transplant (BMT) and cellular therapy. He focuses on treating people with blood cancers using intensive therapies that can offer the potential for a cure.

Transplants and cellular therapy can be life‑saving for some of the most aggressive blood cancers. Dr. Rashidi has led a multicenter clinical trial that studied chemotherapy combined with donor lymphocyte infusion, also known as DLI, for patients with acute leukemia that returned after BMT.

Dr. Rashidi’s research focuses on the microbiome, the community of bacteria that live in and on the human body, and how it influences patient outcomes after intensive blood cancer treatment. These treatments often involve chemotherapy and antibiotics, which can disrupt the microbiome. This disruption, called dysbiosis, can increase the risk of serious infections and affect treatment‑related complications.

Dr. Rashidi’s work examines how differences in individual microbiomes influence how patients respond to blood cancer treatments and how various therapies change the microbiome over time. Using these insights, Dr. Rashidi aims to develop better strategies to prevent and treat dysbiosis and improve outcomes for patients receiving treatment for blood cancers.

Area of Clinical Practice
Blood and marrow transplantation, cellular therapy

“At Fred Hutch, results from groundbreaking research are combined with the highest standard of care to offer the optimal treatment to each patient.”

— Dr. Rashidi

Why did you choose oncology?

I became familiar with cancer from a young age, having seen how cancer affected my grandmother. With little knowledge at the time, cancer appeared like an incurable condition to me. I chose oncology to change this.

What is your approach to care and treatment?

I try to be creative. By combining conventional knowledge with new data coming from research, I try to individualize the care I offer. I let this paradigm evolve as the patient goes through different stages of treatment. Here at Fred Hutch, all aspects of care, from sharing information to acute care to chronic complications and social support, are equally considered. I am happy to be part of this large multidisciplinary team.

Diseases Treated

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Aplastic Anemia

Chronic Lymphocytic Leukemia

Chronic Myeloid Leukemia

Hodgkin Lymphoma

Leukemia

Multiple Myeloma

Myelodysplastic Syndrome

Myeloproliferative Neoplasms

Non-Hodgkin Lymphoma

Research Interests

Impact of microbiome on outcomes of intensive therapy in patients with hematologic malignancies

Languages

English
Farsi

Education and Experience

Fellowship, Hematology and Medical Oncology, Washington University

Residency, Internal Medicine, Eastern Virginia Medical School

PhD, Biogerontology, Newcastle University

MD, Tehran University School of Medicine

Board Certifications

Hematology, 2016; Medical Oncology, 2016; American Board of Internal Medicine

Clinical Trials

We make promising new treatments available to you through studies called clinical trials led by Fred Hutch physicians and researchers. Many of these trials at Fred Hutch have led to FDA-approved treatments and have improved standards of care globally. Together, you and your physician can decide if a study is right for you.

Find a Clinical Trial Led by Dr. Rashidi

Publications

Many of our Fred Hutch physicians and researchers conduct ongoing research to improve standards of patient care. Their work is evaluated by others in their field and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this Fred Hutch physician has written.

View Dr. Rashidi's Publications

Your Care Team

At Fred Hutch, you receive care from a team of providers with extensive experience in your disease. Your team includes physicians, a patient care coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like registered dietitians, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders. 

Meet Other Providers

Insurance

Fred Hutch accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

More About Insurance

Contact Information